SCHEMBL16669243

SCHEMBL16669243

CCCCOCCOc1ccccc1OCCOCCCC

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.60
CYP2C19 P33261 3/20 0.60
CYP2C9 P11712 2/20 0.60
L3MBTL1 Q9Y468 6/20 0.53
ALDH1A1 P00352 5/20 0.50
LMNA P02545 3/20 0.50
KDM4E B2RXH2 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
CYP2D6 P10635 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
MAPT P10636 2/20 0.48
NPSR1 Q6W5P4 1/20 0.48
TSHR P16473 1/20 0.48
KMT2A Q03164 1/20 0.47
PTK2B Q14289 1/20 0.47
LTA4H P09960 1/20 0.47
JAK2 O60674 1/20 0.47
GAA P10253 1/20 0.47
RARB P10826 1/20 0.46
CYP19A1 P11511 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16676018 1.00 CYP1A2 (0.60) CYP1A2CYP2C19CYP2C9L3MBTL1ALDH1A1
SCHEMBL16667608 1.00 CYP1A2 (0.60) CYP1A2CYP2C19CYP2C9L3MBTL1ALDH1A1
SCHEMBL16676015 0.94 CYP1A2 (0.55) CYP1A2CYP2C19CYP2C9L3MBTL1ALDH1A1
SCHEMBL16676017 0.92 LMNA (0.54) CYP1A2CYP2C19CYP2C9L3MBTL1ALDH1A1
1,2-Dibutoxybenzene SCHEMBL29428927 0.89 CYP1A2 (0.72) CYP1A2CYP2C19CYP2C9L3MBTL1LMNA
1,2-Dibutoxybenzene SCHEMBL1226749 0.89 CYP1A2 (0.72) CYP1A2CYP2C19CYP2C9L3MBTL1LMNA
SCHEMBL1710089 0.89 CYP2C19 (0.53) CYP1A2CYP2C19CYP2C9L3MBTL1ALDH1A1
SCHEMBL23131001 0.88 CYP1A2 (0.52) CYP1A2CYP2C19CYP2C9L3MBTL1ALDH1A1
SCHEMBL10584768 0.87 CYP1A2 (0.83) CYP1A2CYP2C19CYP2C9L3MBTL1ALDH1A1
SCHEMBL23054276 0.87 CYP1A2 (0.83) CYP1A2CYP2C19CYP2C9L3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10323204-B2 Low viscosity, low volatility lubricating oil basestocks EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2019-06-18 US disclosed
US-10323204-B2 Low viscosity, low volatility lubricating oil basestocks EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2019-06-18 US disclosed
WO-2015060985-A1 LOW VISCOSITY, LOW VOLATILITY LUBRICATING OIL BASESTOCKS EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2015-04-30 WO disclosed
US-20150119307-A1 LOW VISCOSITY, LOW VOLATILITY LUBRICATING OIL BASESTOCKS EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2015-04-30 US disclosed
US-20150119307-A1 LOW VISCOSITY, LOW VOLATILITY LUBRICATING OIL BASESTOCKS EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2015-04-30 US disclosed
US-20150119307-A1 LOW VISCOSITY, LOW VOLATILITY LUBRICATING OIL BASESTOCKS EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2015-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10323204-B2 Low viscosity, low volatility lubricating oil basestocks TYK2, JAK1, CEL CYP1A2 363/4885CYP2C19 436/4885CYP2C9 415/4885
US-20150119307-A1 LOW VISCOSITY, LOW VOLATILITY LUBRICATING OIL BASESTOCKS TYK2, JAK1, CEL CYP1A2 363/4885CYP2C19 436/4885CYP2C9 415/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.